The Clinical Use of Monolaurin as a Dietary Supplement: A Review of the Literature

被引：17

作者：

Barker, Lisa A. ^{[1
]}

Bakkum, Barclay W. ^{[2
]}

Chapman, Cynthia ^{[3
]}

机构：

[1] Hartsburg Chiropract Hlth Ctr, Danbury, CT USA

[2] Illinois Coll Optometry, 3241 South Michigan Ave, Chicago, IL 60616 USA

[3] Occoquan Family Chiropract, Occoquan, VA USA

来源：

JOURNAL OF CHIROPRACTIC MEDICINE | 2019年 / 18卷 / 04期

关键词：

Anti-Bacterial Agents; Antiviral Agents; GLYCEROL MONOLAURATE; IN-VITRO; STAPHYLOCOCCUS-AUREUS; HUMAN-MILK; NANOCAPSULES; CANDIDA; GROWTH;

D O I：

10.1016/j.jcm.2019.02.004

中图分类号：

R49 [康复医学];

学科分类号：

100215 ;

摘要：

Objective: The purpose of this study was to determine what the peer-reviewed literature says about the clinical applications, therapeutic dosages, bioavailability, efficacy, and safety of monolaurin as a dietary supplement. Methods: This was a narrative review using the PubMed database and the terms "monolaurin" and its chemical synonyms. Commercial websites that sell monolaurin were also searched for pertinent references. The reference sections of the newer articles were searched for any other relevant articles. Consensus was reached among the authors as to what articles had clinical relevance. Results: Twenty-eight articles were found that appeared to address the clinical use of monolaurin. Conclusion: There are many articles that address the antimicrobial effects of monolaurin in vitro. Only 3 peerreviewed papers that evidence in vivo antimicrobial effects of monolaurin in humans were located, and these were only for intravaginal and intraoral-that is, topical-use. No peer-reviewed evidence was found for the clinical use of monolaurin as a human dietary supplement other than as a nutrient.

引用

页码：305 / 310

页数：6

共 34 条

[1]

Ali MA, 2016, CHEM PHARM BULL, V64, P577, DOI 10.1248/cpb.c15-00984

[2] Optimised Anaesthesia to Reduce Post Operative Cognitive Decline (POCD) in Older Patients Undergoing Elective Surgery, a Randomised Controlled Trial [J].